These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1302 related articles for article (PubMed ID: 11818492)

  • 1. Mechanisms of cancer drug resistance.
    Gottesman MM
    Annu Rev Med; 2002; 53():615-27. PubMed ID: 11818492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment.
    Sui X; Chen R; Wang Z; Huang Z; Kong N; Zhang M; Han W; Lou F; Yang J; Zhang Q; Wang X; He C; Pan H
    Cell Death Dis; 2013 Oct; 4(10):e838. PubMed ID: 24113172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance mechanisms to cancer chemotherapy.
    Redmond KM; Wilson TR; Johnston PG; Longley DB
    Front Biosci; 2008 May; 13():5138-54. PubMed ID: 18508576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities.
    Shah K; Rawal RM
    Curr Drug Metab; 2019; 20(14):1114-1131. PubMed ID: 31902353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucins and tumor resistance to chemotherapeutic drugs.
    Jonckheere N; Skrypek N; Van Seuningen I
    Biochim Biophys Acta; 2014 Aug; 1846(1):142-51. PubMed ID: 24785432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of multidrug resistance proteins on the clinical efficacy of cancer therapy.
    Merino V; Jiménez-Torres NV; Merino-Sanjuán M
    Curr Drug Deliv; 2004 Jul; 1(3):203-12. PubMed ID: 16305384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.
    Liu FS
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):239-44. PubMed ID: 19797012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging drug resistance in cancer therapy--review of the First Nordic Conference on Chemoresistance in Cancer Treatment, October 9th and 10th, 1997.
    Lehne G; Elonen E; Baekelandt M; Skovsgaard T; Peterson C
    Acta Oncol; 1998; 37(5):431-9. PubMed ID: 9831371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms for tumour resistance to chemotherapy.
    Pan ST; Li ZL; He ZX; Qiu JX; Zhou SF
    Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):723-37. PubMed ID: 27097837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An outline of main factors of drug resistance influencing cancer therapy.
    Frączek N; Bronisz I; Pietryka M; Kępińska D; Strzała P; Mielnicka K; Korga A; Dudka J
    J Chemother; 2016 Dec; 28(6):457-464. PubMed ID: 27545330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
    Tsuruo T; Naito M; Tomida A; Fujita N; Mashima T; Sakamoto H; Haga N
    Cancer Sci; 2003 Jan; 94(1):15-21. PubMed ID: 12708468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective strategies for tumors affecting chemopreventive metabolism.
    Buters JT
    Clin Cancer Res; 2006 Dec; 12(24):7203-4. PubMed ID: 17189389
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug resistance and apoptosis in cancer treatment: development of new apoptosis-inducing agents active in drug resistant malignancies.
    Tolomeo M; Simoni D
    Curr Med Chem Anticancer Agents; 2002 May; 2(3):387-401. PubMed ID: 12678739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism.
    Joyce H; McCann A; Clynes M; Larkin A
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):795-809. PubMed ID: 25836015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress management by autophagy: Implications for chemoresistance.
    Huang Z; Zhou L; Chen Z; Nice EC; Huang C
    Int J Cancer; 2016 Jul; 139(1):23-32. PubMed ID: 26757106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences.
    Broxterman HJ; Lankelma J; Hoekman K
    Drug Resist Updat; 2003 Jun; 6(3):111-27. PubMed ID: 12860459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of drug resistance and its reversal in cancer.
    Kartal-Yandim M; Adan-Gokbulut A; Baran Y
    Crit Rev Biotechnol; 2016 Aug; 36(4):716-26. PubMed ID: 25757878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy and multidrug resistance in cancer.
    Li YJ; Lei YH; Yao N; Wang CR; Hu N; Ye WC; Zhang DM; Chen ZS
    Chin J Cancer; 2017 Jun; 36(1):52. PubMed ID: 28646911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.